Media Centre

Media Centre

Suspect histoplasmosis in returning travellers from an endemic area presenting with fever and cough

July 22 2019

Histoplasmosis can present in a variety of ways, making it difficult to diagnose. Dr Staffolani and colleagues carried out a systematic review of 835 cases of histoplasmosis (including 45 clusters) from the literature, among immunocompetent patients who had recently returned from an endemic area. Manifestations included fever (91%), cough (55%), constitutional symptoms (58%), headache (52%) and chest pain (41%). Read more

Candida auris found among Russian ICU patients

July 16 2019

Dr Barantsevich and colleagues describe a series of 49 trauma patients at an ICU in Moscow from whom Candida auris was isolated. Fluconazole resistance was widespread. However, no isolates were recovered by monthly swabbing of the hospital environment, healthcare workers’ hands and devices.Read more

WHO endorses Histoplasma antigen as a WHO Essential Diagnostic

July 11 2019

The World Health Organisation has updated its Essential Medicines List to the Histoplasma antigen test, which can be used on urine to diagnose histoplasmosis in 48 hours. Rolling out this test worldwide could save up to 48,000 lives in 5 years.Read more

Cryptococcosis in HIV- patients show atypical presentation, leading to delayed diagnosis

July 08 2019

Cryptococcosis is well known as a complication of HIV/AIDS, but it can also affect those who are immunosuppressed for other reasons. Dr Marr and colleagues describe a set of 138 patients from the US. Around half (49%) had CNS involvement but only just over a quarter (27.8%) had a fever.Read more

LDBio rapid Aspergillus IgG test sensitive and specific for CPA

July 05 2019

Lateral flow rapid diagnostics are sorely needed for many fungal infections. Scientists at the University of Manchester evaluated LDBio's Aspergillus IgG test on patients at the National Aspergillosis Centre (UK). Compared to existing diagnostics, this test was more sensitive (91.6%) and more specific (98.0%) for chronic pulmonary aspergillosis.Read more